SNCA and Parkinson disease: For example, SNCA dysregulation is a major pathological problem in PD, with several miRNAs being investigated and suggested as potential α-SYN regulators, with studies demonstrating that some miRNAs could protect different cell types from neurodegeneration arising from synucleinopathy [205,206].